![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Made Tech Group Plc | LSE:MTEC | London | Ordinary Share | GB00BLGYDT21 | ORD GBP0.0005 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.75 | 18.00 | 19.50 | 18.75 | 18.75 | 18.75 | 85,420 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Cmp Facilities Mgmt Service | 40.25M | -1.6M | -0.0107 | -17.52 | 27.99M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/4/2024 08:14 | major buying pressure incoming this morning in for a massive rise today | ![]() citys2874 | |
22/4/2024 08:13 | agree very cheap may even rise 100 percent today on this news | ![]() citys2874 | |
22/4/2024 08:06 | Might be good enough to finally break the 2.5 year downtrend on the chart. MCap is peanuts. | ![]() parob | |
22/4/2024 08:03 | RNS OUT wow game changing contract £19.5 million wow .....may see 20.00+ today | ![]() citys2874 | |
22/4/2024 07:21 | Shows the potential......... | ![]() chrisdgb | |
22/4/2024 07:18 | That's a BIGGIE for MTEC. Mkt cap is only £14m! | ![]() aishah | |
22/4/2024 07:13 | Some good news at last ! Made Tech awarded £19.5m new contract with DLUHC Made Tech, a leading provider of digital, data and technology services to the UK public sector, is pleased to announce that it has been awarded a new contract with The Department for Levelling Up, Housing & Communities ("DLUHC"), worth up to £19.5m revenue to the Group over a 24 month period with a 12 month extension option. Made Tech will work with DLUHC on the design and development of new digital tools and services. The first of these services to be delivered under this contract is expected to be the Privately Rented Property Portal - a national private rented sector database. | ![]() masurenguy | |
22/4/2024 07:06 | That's a hefty contract, with an extension, relative to MTEC's market valuation | ![]() mirabeau | |
10/4/2024 09:54 | Bottom in? | ![]() parob | |
02/4/2024 15:44 | @chris I took that same point away myself, I think it is so beaten up now you buy, hold and forget for a while, if contracts do start coming in we will all be kicking ourselves for being so abstemious in our investments, and yet...! | ![]() bmcollins | |
02/4/2024 15:22 | Thought it was interesting that Richard Penny was very impressed with the FD........ | ![]() chrisdgb | |
02/4/2024 12:47 | Has the new CFO bought any shares since starting? | ![]() gemlotte55 | |
01/4/2024 11:14 | As we know it is dirt cheap, thanks interesting interview… | ![]() chrisdgb | |
30/3/2024 09:20 | Richard Penny, of Crux Asset Management, shares his views on MTEC @55.35. | ![]() masurenguy | |
27/2/2024 16:14 | You just might be lucky and receive a bid. | ![]() sunshine today | |
27/2/2024 16:04 | Biggest ever volume days since company listed Interesting | hamidahamida | |
27/2/2024 08:58 | Decent volume already....... | ![]() chrisdgb | |
26/2/2024 11:02 | Dr Biotech Everyone's holding is miniscule. Ask the institutions who bought the IPO at 122p in September 2021. | ![]() eagle eye | |
26/2/2024 10:50 | CEO says: 'I look forward to updating our stakeholders further as we progress through 2024.' I'm surprised there are any stakeholders left. I guess only those burnt at the stake LOL | ![]() eagle eye | |
26/2/2024 09:53 | Certainly wouldn't compare it to a bio - they almost always have little to no revenue and a just a gamble on making clinical progress. However I get the point that it needs to become profitable - or more to the point show that it can deliver profitable projects. At the moment its just blather "experienced senior management" bit of self promotion - where's the proof they can deliver? My holding here is miniscule, and I won't increase it until I have some confidence that they know what they are doing. | ![]() dr biotech | |
26/2/2024 09:41 | Booking down 61% & revenue down 7% | blackhorse23 | |
26/2/2024 09:29 | basically it's the same that happens with many biotechnology companies, whose EV is also lower than the cash at hand. They collect cash from shareholders through an IPO or rights issue, and then burn that cash reporting period after reporting period because they spend the money in R&D without revenue from any new medicine. Made Tech got 12M and now there're just 7.9M. certainly it seems in the last report the cash outflow is due to working capital movements, but it must show it can generate cash to change the current market sentiment. | ![]() gusrezo | |
26/2/2024 08:56 | Basically reads that any new contract would be a massive bonus....... | ![]() chrisdgb | |
26/2/2024 08:51 | With £7.9m net cash, the EV is currently only £5.55m @the current shareprice. | ![]() masurenguy | |
26/2/2024 07:11 | Interim Results for the six months ended 30 November 2023 Strong profit performance in line with management expectations Made Tech Group announce its unaudited half year results for the six months ended 30 November 2023. Strategic and Operational highlights ● Adjusted EBITDA up 180% to £1.4m (H1 FY23: £0.5m) with Adjusted EBITDA margin increasing significantly to 37.1% (H1 F23: 32.9%) on revenue down 7% at £19.1m (H1 FY23: £20.6m) ● Net Cash £7.9m (£9.0m) ● Ongoing investment in senior leadership and commercial team to drive continuing programme of growth and productivity initiatives ● Strategic drive by government to digitally transform public services in an agile and cost effective manner means that Made Tech is well placed to deliver long term growth Current Trading and Outlook ● The Group remains on track to meet FY24 profit expectations, with revenue slightly down on prior year ● Despite the challenging market and uncertainty created by the forthcoming general election, the Board anticipates further profit improvement in FY25 as a result of ongoing productivity and cost control initiatives ● Healthy Contracted Backlog of £61.3m (£47.8m) underpins revenue expectations for FY24 and into FY25 Rory MacDonald, CEO of Made Tech, said: "Made Tech is focused on ensuring that it is fit and ready to capitalise on the structural growth opportunities that we see in the UK public services market, with an efficient, right-sized cost base, experienced senior management, and an achievable strategic growth plan in place, whilst also maintaining our reputation for excellence amongst our clients. We are making progress, delivering improvements on profitability and cash generation and appointing key new members to our team, and I look forward to updating our stakeholders further as we progress through 2024." | ![]() masurenguy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions